FLAREX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flarex, and what generic alternatives are available?
Flarex is a drug marketed by Harrow Eye and is included in one NDA.
The generic ingredient in FLAREX is fluorometholone acetate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluorometholone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLAREX?
- What are the global sales for FLAREX?
- What is Average Wholesale Price for FLAREX?
Summary for FLAREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Patent Applications: | 1,981 |
| Drug Prices: | Drug price information for FLAREX |
| What excipients (inactive ingredients) are in FLAREX? | FLAREX excipients list |
| DailyMed Link: | FLAREX at DailyMed |
Pharmacology for FLAREX
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for FLAREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | FLAREX | fluorometholone acetate | SUSPENSION/DROPS;OPHTHALMIC | 019079-001 | Feb 11, 1986 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
